Discover open access scientific publications

Search, annotate, share and cite publications

Publications by Anne Catrine Martinsen

Experiences From Introducing Standardized High Dose 131i-mIBG Treatment of Children With Refractory Neuroblastoma: Differences in Effective Dose to Patients and Exposure to Caregivers

Journal of Nuclear Medicine & Radiation Therapy

2015

English

Related publications

Thyroid and Hepatic Function After High-Dose 131i-Metaiodobenzylguanidine (131i-Mibg) Therapy for Neuroblastoma

Pediatric Blood and Cancer

English

Prognostic Values of Initial Responses to Low-Dose 131i-Mibg Therapy in Patients With Malignant Pheochromocytoma and Paraganglioma

Annals of Nuclear Medicine

English

Toxicity of Upfront 131i-Metaiodobenzylguanidine (131i-Mibg) Therapy in Newly Diagnosed Neuroblastoma Patients: A Retrospective Analysis

European Journal of Nuclear Medicine and Molecular Imaging

English

Feasibility of Administering High-Dose131I-Mibg Therapy to Children With High-Risk Neuroblastoma Without Lead-Lined Rooms

Pediatric Blood and Cancer

English

Treatment of Poor-Risk Neuroblastoma Patients With High-Dose Chemotherapy and Autologous Peripheral Stem Cell Rescue

Bone Marrow Transplantation

Transplantation

Hematology

1997

English

From Dermal Exposure to Internal Dose

Journal of Exposure Science and Environmental Epidemiology

English

Hormonal and Renal Differences Between Low Dose and High Dose Angiotensin Converting Enzyme Inhibitor Treatment in Patients With Chronic Heart Failure.

Heart

Cardiovascular Medicine

Cardiology

1996

English

Feasibility and Advantage of Adding 131i-Mibg to 90y-Dotatoc for Treatment of Patients With Advanced Stage Neuroendocrine Tumors

English

Omeprazole and High Dose Ranitidine in the Treatment of Refractory Reflux Oesophagitis.

Archives of Disease in Childhood

English

Amanote Research

Discover open access scientific publications

Search, annotate, share and cite publications

Publications by Anne Catrine Martinsen

Experiences From Introducing Standardized High Dose 131i-mIBG Treatment of Children With Refractory Neuroblastoma: Differences in Effective Dose to Patients and Exposure to Caregivers

Related publications

Thyroid and Hepatic Function After High-Dose 131i-Metaiodobenzylguanidine (131i-Mibg) Therapy for Neuroblastoma

Prognostic Values of Initial Responses to Low-Dose 131i-Mibg Therapy in Patients With Malignant Pheochromocytoma and Paraganglioma

Toxicity of Upfront 131i-Metaiodobenzylguanidine (131i-Mibg) Therapy in Newly Diagnosed Neuroblastoma Patients: A Retrospective Analysis

Feasibility of Administering High-Dose131I-Mibg Therapy to Children With High-Risk Neuroblastoma Without Lead-Lined Rooms

Treatment of Poor-Risk Neuroblastoma Patients With High-Dose Chemotherapy and Autologous Peripheral Stem Cell Rescue

From Dermal Exposure to Internal Dose

Hormonal and Renal Differences Between Low Dose and High Dose Angiotensin Converting Enzyme Inhibitor Treatment in Patients With Chronic Heart Failure.

Feasibility and Advantage of Adding 131i-Mibg to 90y-Dotatoc for Treatment of Patients With Advanced Stage Neuroendocrine Tumors

Omeprazole and High Dose Ranitidine in the Treatment of Refractory Reflux Oesophagitis.